Pyoderma gangrenosum is strongly associated with inflammatory bowel disease and exhibits pathergy, occurring at sites ofprevious minor trauma. A patient is presented with a 21 year history of extensive ulcerative colitis, who developed pyoderma gangrenosum and arthralgia while receiving high dose corticosteroids for active ulcerative colitis. The arthralgia exhibited pathergy affecting particularly the left temporomandibular joint, which was stressed by an asymmetric bite, and the left elbow, which had been fractured many years previously. This prompted the hypothesis that neutrophils in this condition may be marginated, as a result of increased stickiness ofeither the neutrophil or the vascular endothelium. The introduction of heparin therapy was associated with rapid resolution ofthe arthralgia, pyoderma gangrenosum, and ulcerative colitis. (Gut 1995; 37: 585-588) 
It may occur at any site, commonly affecting the legs, and exhibits pathergy -that is, occurring at sites of previous minor trauma such as needle puncture.3 Its presence is not closely related to the activity of colitis and it may even occur after colectomy.4 5 In In both conditions neutrophil abnormalities have been reported, including decreased migration into skin windows, reduced chemotaxis, abnormal phagocytosis, and decreased bactericidal activity.14 [19] [20] [21] In the case presented here the pathergic nature of the patient's arthritis led us to the hypothesis that increased neutrophil adherence to vascular endothelium might be the underlying abnormality. The marginated neutrophils would then be ready to migrate into adjacent tissue in response to minor local trauma. In view of the report of a reduction in the sulphated proteoglycan content of the vascular endothelium in inflammatory bowel disease22 we speculated that heparin therapy might reverse this defect and reduce neutrophilendothelium adherence.
Case report A 42 year old woman with a 21 year history of extensive ulcerative colitis, developed a typical violaceous ulcerating lesion of pyoderma gangrenosum over the left ankle (Fig 1) at a time when her colitis was moderately active. She is a lifelong non-smoker and has no family history of inflammatory bowel disease. Her colitis had not been in complete remission for 20 months and for the two months prior to the development of the skin lesion she had required oral corticosteroid therapy (prednisolone ¢'30 mg/day) with which she was compliant, in addition to her usual maintenance therapy of sulphasalazine 1 g twice daily. Two weeks before the appearance of the skin lesion she had developed a widespread severe arthralgia particularly affecting the left temporomandibular joint, left elbow, both knees, and ankle joints. She has an asymmetric bite and the affected temporomandibular joint was on dental review noted to be susceptible to trauma as a result of this asymmetry; similarly the painful elbow had been fractured many years previously but had been pain free for years. The pain from the left temporomandibular joint was so severe she could not take solid food.
On admission haemoglobin was 10-1 g/dl, erythrocyte sedimentation rate 46 mm in one hour, serum C reactive protein 35 mg/l, and albumin 38 g/l. Sigmoidoscopy shortly before admission showed liquid stool and red granular mucosa. A biopsy was not taken from the skin lesion because of the risk of poor healing at that site. In view of the pronounced rise in faecal lactoferrin excretion that we have noted in inflammatory bowel disease23 and the Dzuarakanath, Yu, Brookes, PTvce, Rhodes role of lactoferrin in promoting neutrophil adhesion,24-27 serum lactoferrin was measured using a sandwich enzyme linked immunosorbent assay (ELISA) and found to be 489 ng/ml, compared with 144 ng/ml (9500 confidence limits 17 (Fig 2) . After 10 days of intravenous heparin therapy, maintenance therapy with subcutaneous calcium heparin was introduced, maintaining an activated partial thromboplastin ratio between 1.5 and 2 0. It was possible to withdraw the prednisolone completely and there was gradual resolution of the pyoderma gangrenosum (Fig  3) . The serum C reactive protein and serum albumin both improved during heparin therapy (Fig 2) . Sixteen months later the patient remains well without corticosteroid therapy with colitis in complete remission, skin lesion healed, and no joint pain.
Discussion
The dramatic response to heparin in this patient is in keeping with the hypothesis that increased neutrophil-endothelial adherence resulted in generalised margination of neutrophils, which in turn was responsible for the pyoderma gangrenosum and pathergic arthritis. Neutrophil adherence to endothelium was recognised by Dutrochet in (a) inhibition of local formation of thrombin, which itself activates neutrophils32 33 and increases the permeability of endothelial cell layers,34 (b) inhibition of neutrophil elastase,35 which is essential for penetration of the endothelium by the neutrophil, (c) binding of chemokines, involved in margination and adhesion,36 37 (d) inhibition of leucocyte heparanase,38-40 (e) binding of lactoferrin.4 l Many or all of these properties are also held by the normal endothelial proteoglycans (particularly heparan sulphate). If the endothelial effects are critical as seems likely, the long half life of endothelial bound42 heparin may mean that intermittent treatment with minimal systemic anticoagulation could be used to achieve this effect on neutrophil-endothelial adhesion.
Increased neutrophil adherence to endothelium resulting in neutrophil margination provides a plausible explanation for pathergy in pyoderma gangrenosum. The impressive effects of heparin therapy in this case, and in cases of refractory ulcerative colitis43-45 suggests a need for further therapeutic trials in both conditions. 
